personalia

Prof. Dr. Agnes Kant

‘Side effects are not a side issue’

Discovering knowledge about side effects needs to be faster and better. In her oration, Prof. Dr. Agnes Kant, Professor by special appointment of Innovation of Pharmacovigilance, calls for more…

Bob White

Olympus appoints new CEO

Global MedTech company Olympus, announces appointment of a Chief Executive Officer (CEO) aimed at accelerating its ongoing transformation efforts in the medtech space.

Dr Ari Melnick

A new chapter in leukaemia and hematologic disease research

Dr Ari Melnick has been appointed the new Director of the Josep Carreras Leukaemia Research Institute by the Board of Trustees. The institute specialises in biomedical research and precision medicine…

Anastasia Khvorova, PhD

Pioneering work in the field of RNA-based therapies for Huntington's disease

RNA researcher Anastasia Khvorova, PhD, professor of RNA therapeutics at UMass Chan Medical School, will receive this year's Else Kröner Fresenius Prize for Medical Research on May 15, 2025.…

News • Medical and Scientific Affairs Division

Dr. John de Csepel is new CMO at Olympus

Global medtech company Olympus has named Dr. John de Csepel to the role of Chief Medical Officer (CMO), effective immediately.